T-E Meds has distinguished itself from a highly competitive pool of global nominees and has been selected as one of only six companies worldwide to be shortlisted for the “Best New Drug Developer 2025” category at the 12th World ADC Awards.
This recognition highlights T-E Meds’ outstanding achievements in ADC technology platforms and innovative drug development, earning the highest acclaim from international experts.
The interview video:
Related News: